R. Yang

Adult IDH wild-type lower-grade gliomas should be further stratified

Zhifeng Shi, Jinsong Wu, H. Ng, 2017, Neuro-oncology.

Molecular landscape of pediatric type IDH wildtype, H3 wildtype hemispheric glioblastomas

Wei-wei Wang, Zhifeng Shi, Hong Chen, 2022, Laboratory Investigation.

Pediatric low-grade gliomas can be molecularly stratified for risk

Wei-wei Wang, Zhifeng Shi, W. Poon, 2018, Acta Neuropathologica.

NCAPG2 Is a Novel Prognostic Biomarker and Promotes Cancer Stem Cell Maintenance in Low-Grade Glioma

Lei Zhang, Shu Yang, R. Yang, 2022, Frontiers in Oncology.

Identification of subsets of IDH-mutant glioblastomas with distinct epigenetic and copy number alterations and stratified clinical risks

H. Noushmehr, T. Malta, Zhifeng Shi, 2019, Neuro-oncology advances.

Whole‐exome sequencing revealed mutational profiles of giant cell glioblastomas

Zhifeng Shi, Y. Mao, H. Ng, 2019, Brain pathology.

Low‐grade BRAF V600E mutant oligodendroglioma‐like tumors of children may show EGFR and MET amplification

Zhifeng Shi, Y. Mao, H. Ng, 2020, Brain Pathology.